• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外周血干细胞输注治疗1例RAEB-T患者]

[Peripheral blood stem cell transfusion for a patient with RAEB-T].

作者信息

Fujii H, Nakagawa H, Sonoda Y, Kuzuyama Y

机构信息

Third Department of Internal Medicine, Kyoto First Red Cross Hospital.

出版信息

Rinsho Ketsueki. 1993 Jun;34(6):764-8.

PMID:7690075
Abstract

This report deals with a case of RAEB in transformation (RAEB-T) who received peripheral blood stem cell transfusion (PBSCT) and has remained in complete remission for 15 months. A 51-year-old man was admitted to our hospital with abnormal hematological examinations in August 1991. Peripheral blood showed a WBC of 3,580/microliters with 19% myeloblasts. Bone marrow aspirate revealed slight hypocellularity with 21.2% myeloblasts. Many of these myeloblasts contained Auer rods. He was diagnosed as having RAEB-T. He was treated with low dose Ara-C, followed by the BHAC-VEP regimen and complete remission was obtained 2 months later. After high dose Ara-C regimen, one leukapheresis was performed using CS-3000 during bone marrow recovery. The collected number of CFU-GM, BFU-E and CFU-mix were 4.3, 4.3 and 0.68 x 10(5)/kg b.w., respectively and they were cryoreserved. In November 1991, 16 mg/kg b.w. of busulfan, 120 mg/kg b.w. of cyclophosphamide and rG-CSF were used as a conditioning regimen and PBSCT was performed. The infused number of CFU-GM, BFU-E and CFU -mix were 0.8, 0.9 and 0.14 x 10(5)/kg b.w., respectively. The number of days to reach 500 neutrophils/microliters and 5 x 10(4) platelets/microliters was 17 and 63 days, respectively. He has remained in complete remission for 15 months after PBSCT. PBSCT appears to be one effective therapeutic choice for the treatment of RAEB-T.

摘要

本报告涉及一例转化中的难治性贫血伴原始细胞过多(RAEB-T)患者,其接受了外周血干细胞输注(PBSCT)并已完全缓解15个月。一名51岁男性于1991年8月因血液学检查异常入院。外周血显示白细胞计数为3580/微升,原始粒细胞占19%。骨髓穿刺显示轻度细胞减少,原始粒细胞占21.2%。许多这些原始粒细胞含有奥氏小体。他被诊断为RAEB-T。他接受了小剂量阿糖胞苷治疗,随后采用BHAC-VEP方案,2个月后获得完全缓解。在高剂量阿糖胞苷方案后,在骨髓恢复期间使用CS-3000进行了一次白细胞单采。采集的集落形成单位-粒细胞巨噬细胞(CFU-GM)、爆式红系集落形成单位(BFU-E)和混合集落形成单位(CFU-mix)数量分别为4.3、4.3和0.68×10⁵/kg体重,并且进行了冷冻保存。1991年11月,使用16mg/kg体重的白消安、120mg/kg体重的环磷酰胺和重组人粒细胞集落刺激因子(rG-CSF)作为预处理方案并进行了PBSCT。输注的CFU-GM、BFU-E和CFU-mix数量分别为0.8、0.9和0.14×10⁵/kg体重。达到500个中性粒细胞/微升和5×10⁴个血小板/微升的天数分别为17天和63天。PBSCT后他已完全缓解15个月。PBSCT似乎是治疗RAEB-T的一种有效治疗选择。

相似文献

1
[Peripheral blood stem cell transfusion for a patient with RAEB-T].[外周血干细胞输注治疗1例RAEB-T患者]
Rinsho Ketsueki. 1993 Jun;34(6):764-8.
2
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
3
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).对于转化型难治性贫血伴原始细胞增多(RAEB-t)患者,给予急性髓系白血病(AML)型化疗联合粒细胞集落刺激因子(G-CSF)治疗时,缓解率高,但缓解持续时间短。
Cytokines Mol Ther. 1995 Mar;1(1):21-8.
4
[Bone marrow re-transplantation following a busulfan and cyclophosphamide regimen].白消安和环磷酰胺方案后的骨髓再次移植
Rinsho Ketsueki. 1990 Jul;31(7):974-8.
5
[Hematological recovery after peripheral blood stem cell transplantation followed by recombinant granulocyte colony-stimulating factor].外周血干细胞移植后联合重组粒细胞集落刺激因子的血液学恢复
Rinsho Ketsueki. 1993 Aug;34(8):904-11.
6
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.与骨髓细胞相比,在急性髓系白血病患者中使用外周血干细胞进行自体移植可实现更快的植入和相当的无病生存期。
Bone Marrow Transplant. 1999 Sep;24(5):467-72. doi: 10.1038/sj.bmt.1701920.
7
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.伊达比星与阿糖胞苷用于高危骨髓增生异常综合征的诱导缓解及维持治疗
Haematologica. 1997 Nov-Dec;82(6):660-3.
8
Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome.在首次完全缓解的急性髓系白血病中,采用粒细胞集落刺激因子动员的自体外周血干细胞移植(PBSCT)。强化治疗对预后的作用。
Bone Marrow Transplant. 1998 Feb;21(4):375-82. doi: 10.1038/sj.bmt.1701102.
9
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.伊达比星和阿糖胞苷用于高危骨髓增生异常综合征的诱导和维持治疗
Haematologica. 1997 Sep-Oct;82(5 Suppl):9-12.
10
[A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].1例RAEB-t经G-CSF治疗,在接受MST-16治疗后出现完全缓解,继发可逆性白血病
Gan To Kagaku Ryoho. 1991 Sep;18(12):2155-8.